Seeyoun Lee

Center for Breast Cancer

H指数:28

被引数:2,288

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Plasma metabolomic signatures associated with pathologic complete response in locally advanced breast cancer following neoadjuvant chemotherapy

局部晚期乳腺癌新辅助化疗后病理完全缓解相关的血浆代谢组学特征

BMC Cancer

IF3.4

2026-09-010

Prognostic impact of HER2-low versus HER2-zero expression by hormone receptor status in early breast cancer: a retrospective cohort study

激素受体状态下HER2低表达与HER2零表达对早期乳腺癌预后的影响：一项回顾性队列研究

BMC Cancer

IF3.4

2026-08-240

Clinicopathologic Characteristics and Lymph Node Status in the NAUTILUS Clinical Trial:KBCSG-21

European Journal of Surgical Oncology

IF2.9

2026-02-020

PRE

A Randomized Trial of Sentinel Node Biopsy Omission After Neoadjuvant Systemic Therapy in Clinically Node-Negative or Selected Node-Positive Breast Cancer

一项关于新辅助系统性治疗后临床淋巴结阴性或选择性淋巴结阳性乳腺癌中哨兵淋巴结活检省略的随机试验

Journal of Breast Cancer

IF0

2025-12-010

Effectiveness of Multi-Layer Perceptron-Based Binary Classification Neural Network in Detecting Breast Cancer Through Nine Human Serum Protein Markers

基于多层感知器二元分类神经网络通过九种人类血清蛋白质标记物检测乳腺癌的有效性

Cancers 2025, Vol. 17, Page 2832

IF4.4

2025-08-290

Causal Attributions in Patients With Breast and Gynecological Cancers: A Scoping Review

乳腺癌和妇科癌症患者中的因果归因：一项范围综述

Psycho-Oncology

IF3.5

2025-08-240

OAAI

PALB2 germline pathogenic variants: frequency, clinical features, and functional analysis of c.3350+5G>A variant in 3987 Korean cancer patients

ESMO OPEN

IF8.3

2025-03-010

PRE

What to expect from the No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS] trial (KBCSG-21): Clinicopathologic characteristics and axillary lymph node status of enrolled patients

CANCER RESEARCH

IF16.6

2024-05-020

PRE

Effectiveness of 24-week mobile application based human coaching program for controlling weight, BMI and body composition in overweight/obese breast cancer survivors: Single-arm prospective cohort study

CANCER RESEARCH

IF16.6

2024-05-020

PRE

Exploring the impact of cancer predisposition gene variants by functional analysis and whole genome sequencing analysis in hereditary cancer patients

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Prevalence and risk factors of PALB2 germline pathogenic variants

CANCER RESEARCH

IF16.6

2024-03-220

PRE

A retrospective pilot study to validate the utility of proteomic biomarkers in the blood for diagnosis of breast cancer

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Questionnaire study of application about sentinel lymph node biopsy surgery in locally advanced breast cancer patients who received neoadjuvant chemotherapy

FRONTIERS IN ONCOLOGY

IF3.3

2023-10-020

OAAI

Clinical features of Li-Fraumeni syndrome in Korea

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Progranulin and Breast Cancer Mortality: 13-Year Follow-Up of a Cohort Study

颗粒蛋白前体与乳腺癌死亡率: 一项队列研究的13年随访

breast cancer

IF3.4

2023-04-011

OAAI

The efficacy and safety of an indocyanine green-hyaluronic acid mixture (LuminoMark™) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial

FRONTIERS IN ONCOLOGY

IF3.3

2023-03-244

OAAI

No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial

BMC CANCER

IF3.4

2022-02-2032

OAAI

The NAUTILUS trial (No Axillary sUrgical Treatment In clinically Lymph node negative patients after UltraSonography): A prospective multicenter randomized phase III trial (NCT04303715)

CANCER RESEARCH

IF16.6

2022-02-150

PRE

Androgen receptor as predictive marker for pathologic complete response in breast cancer with neoadjuvant chemotherapy

CANCER RESEARCH

IF16.6

2022-02-152

PRE

A higher locoregional recurrence rate of nipple areolar complex sparing mastectomy with immediate implant reconstruction

CANCER RESEARCH

IF16.6

2022-02-150

PRE

Seeyoun Lee

个人简介

教育背景

工作经历

荣誉奖项

研究方向